Domov › Rak ledvic (renocelularni karcinom) › Michigan › Ann Arbor

Klinične študije za Rak ledvic (renocelularni karcinom) v Ann Arbor, MI

12 študij za Rak ledvic (renocelularni karcinom) išče udeležence na lokacijah v Ann Arbor in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.

Uradno besedilo študije (angleško)

Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci

Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
Huron Gastroenterology PC, Ypsilanti · 7 mi stran
Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi stran
in še 4

Starost 40–75 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT05334069

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Vključevanje udeležencevFaza 2

Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
Huron Gastroenterology PC, Ypsilanti · 7 mi stran
Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi stran
in še 4

Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT03866382

Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial

Vključevanje udeležencevFaza 2

Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
University of Michigan Rogel Cancer Center, Ann Arbor
Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi stran
in še 4

Starost 18 in več · Vsi spoli · Posodobljeno 18. sep. 2026 · NCT05327686

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

Vključevanje udeležencevFaza 1

University of Michigan, Ann Arbor

Starost 18 in več · Vsi spoli · Posodobljeno 15. sep. 2026 · NCT07195916

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

Vključevanje udeležencevFaza 3

Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi stran
Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · 15 mi stran
Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · 18 mi stran

Starost 18 in več · Vsi spoli · Posodobljeno 2. sep. 2026 · NCT06661720

Study of DCC-2812 in Participants With Advanced Genitourinary Cancers

Vključevanje udeležencevFaza 1

University of Michigan, Ann Arbor

Starost 18 in več · Vsi spoli · Posodobljeno 18. avg. 2026 · NCT06966024

Inulin Gel in Combination With Ipilimumab and Nivolumab for the Treatment of Metastatic or Locally Advanced Kidney Cell Cancer, ICON Trial

Vključevanje udeležencevFaza 1/2

University of Michigan Comprehensive Cancer Center, Ann Arbor

Starost 18 in več · Vsi spoli · Posodobljeno 31. jul. 2026 · NCT06866262

Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer

Vključevanje udeležencevFaza 3

Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi stran
Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · 15 mi stran
Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · 18 mi stran

Starost 18 in več · Vsi spoli · Posodobljeno 11. jun. 2026 · NCT07383441